HIV

HIV, or human immunodeficiency virus, is the virus that causes acquired immune deficiency syndrome (AIDS). HIV attacks the immune system by entering and destroying CD4+ T cells, a type of white blood cell that is vital to fighting off infection. The destruction of these cells leaves people with HIV vulnerable to other pathogens and complications. NIAID supports a comprehensive HIV research program that provides valuable scientific information about the basic biology of HIV and the immune response to the virus, while developing novel approaches for diagnosing, preventing, and treating HIV. 

Hepatitis

Viral hepatitis is an inflammatory liver disease caused by infection with any of the known hepatitis viruses—A, B, C, D and E. Hepatitis B and C can be transmitted sexually and account for most of the global hepatitis burden. NIAID supports programs to improve point-of-care testing and design a vaccine for hepatitis C virus and to cure chronic hepatitis B infection. 

Careers & Training

NIAID offers many ways of participating in the support of our mission of finding better methods of disease prevention, diagnosis and treatment. Find a scientific or administrative career or training opportunity at NIAID campuses; explore training and career development grants; or learn what is required and available once you have a grant.

Grants for Use at Other Organizations

Training and Career Development Grant Programs for Use at Other Organizations

NIAID uses a variety of funding mechanisms to develop and support the next generation of biomedical researchers — people just entering graduate school, finishing their doctorates, or coming in from other fields. These awards enable promising scientists to gain education and experience.

Collaborative Clinical Research Branch (CCRB)

About CCRB

  • Vision – To reduce the impact of infectious diseases globally through timely clinical research.
  • Mission – To advance clinical research in infectious diseases through government partnerships and collaborations to inform public health practices.
  • Values – Integrity; Cultural Sensitivity; Scientific Excellence; Mutual Trust and Respect; Perseverance

Special Projects

NIAID Special Projects are clinical research partnerships in strategic locations that address specific research needs and support pandemic preparedness or other NIAID priorities which are not readily accomplished through other mechanisms. The Special Projects:

  • Address scientifically critical questions of mutual interest to NIAID and the host-country or partner
  • Are often, but not exclusively, with another country, and are managed through government-to-government agreements with shared governance frameworks and resources 
  • Allow NIAID to maintain a global network of partners with scientific and operations capabilities, enabling a rapid collaborative research response to unpredictable or emergent infectious disease threats
  • Preserve clinical research infrastructure and capacity between infectious disease threats.

Goals

  1. Develop and implement collaborative clinical research to generate new knowledge and establish strong scientific foundations
  2. Optimize and maintain clinical research infrastructure to ensure readiness
  3. Support NIAID and Special Project priorities by cultivating strong relationships

Division of Clinical Research (DCR Special Projects)

DCR Global Research Partnerships

a world map with the partnership countries highlighted in red.

NIAID global clinical research partners are with the Democratic Republic of Congo, Guinea, Indonesia, Liberia, Mali, Mexico and the United States of America.

Credit: NIAID

Resources

  • CCRB Laboratories
  • ClinRegs is an online database of country-specific clinical research regulatory information designed to assist in planning and implementing international clinical research.
  • Clinical Trials

Contact Information

For more information about CCRB, please email CCRB_INFO@niaid.nih.gov.

Postbaccalaureate Training in NIAID

Updates on Recruitment

The Intramural Program has paused the recruitment of specific training programs—for the latest updates and details, visit the NIH Office of Intramural Training & Education.

Who Can Apply | How to Apply | Funding | What It's Like to Train at NIAID

Postbaccalaureate research trainees (postbacs) at NIAID engage in research at the forefront of immunologic, allergic, and infectious diseases. Postbacs conduct research in NIAID laboratories located in Maryland and Montana (Rocky Mountain Laboratories in Hamilton), which provides a unique scientific research training environment in basic, translational, and clinical research for recent college graduates considering graduate or professional school (master’s, Ph.D., M.D., or equivalent graduate degree) in healthcare and STEM fields. Postbacs spend one to two years performing full-time research under the guidance and direction of an NIAID principal investigator. Trainees have the opportunity to engage and network with experts in diverse scientific research fields while taking advantage of the extensive resources of NIH.

Read more about the Division of Intramural Research and the Vaccine Research Center. Find more information about postbaccalaureate training opportunities from the NIH Office of Training and Education (OITE).

Note: The duration of the program is typically one year; however, the fellowship may be extended for an additional year provided satisfactory performance of the trainee and availability of continued support by the laboratory.

Who Can Apply

Applicants must

  • Be a U.S. citizen or permanent resident

In addition, applicants must meet one of the following criteria: 

  • Have earned a bachelor’s degree within three years of postbac start date
  • Have received a master's degree within six months before the postbac start date

Background Check

Please note any fellowship offer is contingent on your ability to successfully pass a federal background check, which is required for logical and physical access to NIH facilities and systems. As part of the clearance process, you will be asked “In the last year, have you used, possessed, supplied, or manufactured illegal drugs?” This question pertains to the use of controlled substances or drugs as defined under federal law. 

Please be aware that while marijuana may be legal or decriminalized within your home jurisdiction it remains illegal under U.S. federal law. The use, possession, supply, or manufacture of marijuana may preclude you from obtaining the necessary clearances to participate in NIH intramural training programs, even if you were initially offered a position. If you have questions about this policy or would like guidance on the clear- ance process, please reach out to oite@nih.gov (please put “Eligibility Inquiry” in the subject line).

How to Apply

Postbaccalaureate Intramural Research Training Award (IRTA) Program

The postbac IRTA program is designed to provide recent college graduates the opportunity to conduct full-time biomedical research in the resource-rich environment of NIH.

Note: Recent graduates may also apply to the NIH Summer Internship Program to conduct research in an NIAID laboratory if they are enrolled in a degree-granting program the semester following the summer program.

For specific questions, contact the NIAID Office of Research Training and Development.

Funding

Funding is based on NIH appointment type (e.g., IRTA, Special Volunteer). Stipend levels for trainees are published annually and determined based on experience.

Contact Information

For specific questions, contact the NIAID Office of Research Training and Development.

New OMRF Study Aimed at Early Lupus Detection; Participants Sought

Q&A: Decline in Condom Use Indicates Need for Further Education, Awareness

Scientists Discover 18 New Species of Gut Microbes in Search for Origins of Antibiotic Resistance

Media Type
Article
Publish or Event Date
Research Institution
Massachusetts Eye and Ear
Short Title
Scientists Discover 18 New Species of Gut Microbes in Search for Origins of Antibiotic Resistance
Content Coordinator

Grant for Research into Highly Deadly Variant of Tuberculosis

Media Type
Article
Publish or Event Date
Research Institution
Radboud University Medical Center
Short Title
Grant for Research into Highly Deadly Variant of Tuberculosis
Content Coordinator

Breaking the Mold: Kyle David’s Research Challenges Ecological Norms in Yeast Communities

Media Type
Article
Publish or Event Date
Research Institution
Vanderbilt University
Short Title
Breaking the Mold: Kyle David’s Research Challenges Ecological Norms in Yeast Communities
Content Coordinator